Healthcare

Symbiotec Pharmalab Ltd (SYMBIOTEC) — Verified Research

1 piece of verified research from 1 publisher. 1 idea is active.

₹1,250.2 -1.9%as of 29 Oct 2026
Verified Research
1 Buy · 0 Hold · 0 Sell
1 piece of research from 1 publisher

Verified Research on SYMBIOTEC

Published by Verified Research Publishers: Buy / Hold / Sell with entry price, target and outcome on the record. Immutable — every piece is permanent, however it turned out.

Research Consensus
1 Buy · 0 Hold · 0 Sell
Buy 100% · Hold 0% · Sell 0%
Conviction
High · 1
Horizon
12m · 1

Research History

Entry ₹1,129.4 (1 of 1) · Target ₹1,330 (1 of 1) · Latest 11 Sept 2026

SYMBIOTEC

Symbiotec Pharmalab LtdBUYACTIVE+10.7%
Vishwa Mohit · @stockbaaz · 11 Sept 2026 · 12m horizon

Symbiotec Pharmalab Cmp 1100 Tgt 1330 Sl 1050

ENTRY
₹1,129.4
TARGET
₹1,330
LATEST
₹1,250.2
CONVICTION
High

Read full idea →

Research activity by month
2026-091 Buy

People covering SYMBIOTEC

Each person’s latest rating or view is shown — it is theirs, not myInvestorCircle’s.

Research publishers (1)
Vishwa Mohit
@stockbaaz
BUY
Sign in to see Your Circle's take on SYMBIOTEC, post your own view, or track this stock.Sign in to take part
My Investor Circle is a technology platform where members share their own investment ideas and build public track records. We do not provide personalised investment advice or recommend any securities. Unless explicitly shown on a profile, we do not verify that a member is registered with SEBI or any other regulatory authority.
© 2026 My Investor Circle · myinvestorcircle.com